Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027

Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027

The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, Lack of skilled professionals is one of the challenge for which may inhibit the growth of this market.

“The Slide-Staining Systems in instruments is projected to grow at CAGR of 7.4% from 2022 to 2027”

Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments). The growth of this market is majorly driven by the factors such as benefits of automation, the greater capacity of slide staining systems, and the elimination of manual errors, and delivering high throughput staining capabilities for histology laboratories.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”

In this report, the tissue diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the economic growth in the countries of this region, large population base, the rising prevalence of chronic diseases, the rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)

By Designation: C-level (30%), Director-level (34%), and Others (36%)

By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)

List of Companies Profiled in the Report

F. Hoffmann-La Roche Ltd. (Switzerland)

Danaher Corporation (US)

Thermo Fisher Scientific, Inc (US)

Abbott (US)

Agilent Technologies Inc. (US)

Merck KGAA (Germany)

SAKURA FINETEK JAPAN CO., LTD (Japan)

Abcam Plc. (UK)

Becton, Dickinson and Company (BD) (US)

Bio SB (US)

Biogenix (US)

Cell Signaling Technology, Inc (US)

Histo-Line Laboratories (Italy)

SLEE Medical GMBH (Germany)

Hologic Inc. (US).

Jinhua YIDI Medical Appliance Co. Ltd (China)

MEDITE MEDICAL GMBH (Germany)

Cellpath Ltd (UK)

Amos scientific Pty Ltd (Australia)

Dipath S.P.A (Italy)

KFBIO KONFOONG BIOINFORMATION TECH CO

LTD (China), Diagnostic BioSystems Inc. (US)

3DHISTECH LTD (Hungary)

RWD LIFE SCIENCE CO., LTD. (China)

Dakewe Biotech Co., Ltd. (China)

Research Coverage:

This report studies the tissue diagnostics market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total tissue diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on tissue diagnostics products offered by the top 25 players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by product, and region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the tissue diagnostics market

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the tissue diagnostics market


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS
    • MARKET SCOPE
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED
    • CURRENCY
    • LIMITATIONS
    • MARKET STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • GROWTH FORECAST
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ANALYSIS
    • ASSUMPTIONS FOR THE STUDY
    • INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
      • COVID-19-SPECIFIC ASSUMPTIONS
    • RISK ASSESSMENT
      • Table RISK ASSESSMENT
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • TISSUE DIAGNOSTICS MARKET OVERVIEW
    • TISSUE DIAGNOSTICS MARKET, BY PRODUCT
    • ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY DISEASE & COUNTRY
    • GEOGRAPHIC SNAPSHOT OF TISSUE DIAGNOSTICS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
        • Table PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
        • Table NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
      • TRENDS
    • COVID-19 IMPACT ON TISSUE DIAGNOSTICS MARKET
    • RANGES/SCENARIOS
      • TISSUE DIAGNOSTICS MARKET
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • TECHNOLOGY ANALYSIS
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • INTENSITY OF COMPETITIVE RIVALRY
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF SUBSTITUTES
    • KEY STAKEHOLDERS & BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 END USERS (%)
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR TOP 3 END USERS
    • REGULATORY LANDSCAPE
      • Table INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING TISSUE DIAGNOSTICS MARKET
    • PATENT ANALYSIS
    • KEY CONFERENCES & EVENTS IN 2022-2023
      • Table LIST OF CONFERENCES & EVENTS
    • PRICING ANALYSIS
      • Table PRICE RANGE FOR TISSUE DIAGNOSTICS
    • TRADE ANALYSIS
      • Table IMPORT DATA FOR MICROTOMES, PARTS, AND ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2016-2020 (USD MILLION)
      • Table EXPORT DATA FOR MICROTOMES, PARTS, AND ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2016-2020 (USD MILLION)
    • ECOSYSTEM ANALYSIS
      • Table ROLE IN ECOSYSTEM
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • TISSUE DIAGNOSTICS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
    • CONSUMABLES
      • Table TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2019-2027 (USD MILLION)
      • Table TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY REGION, 2019-2027 (USD MILLION)
      • ANTIBODIES
        • Table TISSUE DIAGNOSTICS MARKET FOR ANTIBODIES, BY REGION, 2019-2027 (USD MILLION)
      • KITS
        • Table TISSUE DIAGNOSTICS MARKET FOR KITS, BY REGION, 2019-2027 (USD MILLION)
      • REAGENTS
        • Table TISSUE DIAGNOSTICS MARKET FOR REAGENTS, BY REGION, 2019-2027 (USD MILLION)
      • PROBES
        • Table TISSUE DIAGNOSTICS MARKET FOR PROBES, BY REGION, 2019-2027 (USD MILLION)
    • INSTRUMENTS
      • Table TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2019-2027 (USD MILLION)
      • Table TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
      • SLIDE-STAINING SYSTEMS
        • Table TISSUE DIAGNOSTICS MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
      • SCANNERS
        • Table TISSUE DIAGNOSTICS MARKET FOR SCANNERS, BY REGION, 2019-2027 (USD MILLION)
      • TISSUE-PROCESSING SYSTEMS
        • Table TISSUE DIAGNOSTICS MARKET FOR TISSUE-PROCESSING SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
      • OTHER INSTRUMENTS
        • Table TISSUE DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
  • TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
    • IMMUNOHISTOCHEMISTRY (IHC)
      • Table TISSUE DIAGNOSTICS MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2019-2027 (USD MILLION)
    • IN SITU HYBRIDIZATION (ISH)
      • Table TISSUE DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2019-2027 (USD MILLION)
    • DIGITAL PATHOLOGY & WORKFLOW MANAGEMENT
      • Table TISSUE DIAGNOSTICS MARKET FOR DIGITAL PATHOLOGY & WORKFLOW MANAGEMENT, BY REGION, 2019-2027 (USD MILLION)
    • SPECIAL STAINING
      • Table TISSUE DIAGNOSTICS MARKET FOR SPECIAL STAINING, BY REGION, 2019-2027 (USD MILLION)
  • TISSUE DIAGNOSTICS MARKET, BY DISEASE
    • INTRODUCTION
      • Table GLOBAL CANCER INCIDENCE, 2018 VS. 2025
      • Table TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2019-2027 (USD MILLION)
    • BREAST CANCER
      • Table BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040
      • Table TISSUE DIAGNOSTICS MARKET FOR BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
    • GASTRIC CANCER
      • Table COLORECTAL CANCER INCIDENCE, BY REGION, 2020 VS. 2040
      • Table TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER, BY REGION, 2019-2027 (USD MILLION)
    • LYMPHOMA
      • Table HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2018 VS. 2025
      • Table NON-HODGKIN LYMPHOMA INCIDENCE, BY REGION, 2018 VS. 2025
      • Table TISSUE DIAGNOSTICS MARKET FOR LYMPHOMA, BY REGION, 2019-2027 (USD MILLION)
    • PROSTATE CANCER
      • Table PROSTATE CANCER INCIDENCE, BY REGION, 2018 VS. 2025
      • Table TISSUE DIAGNOSTICS MARKET FOR PROSTATE CANCER, BY REGION, 2019-2027 (USD MILLION)
    • NON-SMALL CELL LUNG CANCER
      • Table NON-SMALL CELL LUNG CANCER INCIDENCE, BY REGION, 2020 VS. 2040
      • Table TISSUE DIAGNOSTICS MARKET FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2019-2027 (USD MILLION)
    • OTHER DISEASES
      • Table TISSUE DIAGNOSTICS MARKET FOR OTHER DISEASES, BY REGION, 2019-2027 (USD MILLION)
  • TISSUE DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
    • HOSPITALS
      • Table TISSUE DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
    • RESEARCH LABORATORIES
      • Table TISSUE DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
    • PHARMACEUTICAL COMPANIES
      • Table TISSUE DIAGNOSTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table ONCOLOGY CONTRACT RESEARCH ORGANIZATIONS (CROS).
      • Table TISSUE DIAGNOSTICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
    • OTHER END USERS
      • Table TISSUE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2019-2027 (USD MILLION)
  • TISSUE DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table TISSUE DIAGNOSTICS MARKET, BY REGION, 2019-2027 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
      • Table NORTH AMERICA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • US
        • Table US CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
        • Table US: KEY MACROINDICATORS
        • Table LIST OF US FDA-APPROVED PRODUCTS RELATED TO TISSUE DIAGNOSTICS
        • Table US: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table US: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table US: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • CANADA
        • Table CANADA CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table CANADA: KEY MACROINDICATORS
        • Table CANADA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table CANADA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table CANADA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
    • EUROPE
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
      • Table EUROPE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • GERMANY
        • Table GERMANY CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table GERMANY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table GERMANY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table GERMANY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • UK
        • Table UK: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table UK: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table UK: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • FRANCE
        • Table FRANCE CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table FRANCE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table FRANCE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table FRANCE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • ITALY
        • Table ITALY CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table ITALY: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table ITALY: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table ITALY: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • SPAIN
        • Table SPAIN CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table SPAIN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table SPAIN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table SPAIN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • REST OF EUROPE
        • Table LUNG CANCER INCIDENCE IN KEY REST OF EUROPE COUNTRIES, 2020 VS. 2040
        • Table LIVER CANCER INCIDENCE IN KEY REST OF EUROPE COUNTRIES, 2020 VS. 2040
        • Table REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table REST OF EUROPE: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
      • Table ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • CHINA
        • Table CHINA CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table CHINA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table CHINA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table CHINA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • JAPAN
        • Table JAPAN: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
        • Table JAPAN: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table JAPAN: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table JAPAN: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • INDIA
        • Table INDIA CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table INDIA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table INDIA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table INDIA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table INCIDENCE OF CANCER IN REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table REST OF ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table REST OF ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
    • REST OF THE WORLD
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY REGION, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES, BY TYPE, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY DISEASE, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
      • Table REST OF THE WORLD: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • LATIN AMERICA
        • Table KEY LATIN AMERICAN COUNTRIES LUNG CANCER INCIDENCE, 2018 VS. 2025
        • Table KEY LATIN AMERICAN COUNTRIES LIVER CANCER INCIDENCE, 2018 VS. 2025
        • Table KEY LATIN AMERICAN COUNTRIES BREAST CANCER INCIDENCE, 2018 VS. 2025
        • Table LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table LATIN AMERICA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
      • MIDDLE EAST & AFRICA
        • Table AFRICA CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
        • Table MIDDLE EAST & AFRICA: TISSUE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019-2027 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: TISSUE DIAGNOSTICS MARKET, BY END USER, 2019-2027 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
      • Table OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TISSUE DIAGNOSTICS MARKET
    • REVENUE SHARE ANALYSIS
    • MARKET SHARE ANALYSIS
      • Table TISSUE DIAGNOSTICS MARKET: DEGREE OF COMPETITION
    • COMPANY EVALUATION QUADRANT
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY EVALUATION QUADRANT FOR SMES/START-UPS
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • COMPANY FOOTPRINT ANALYSIS
      • COMPANY FOOTPRINT
      • COMPANY REGIONAL FOOTPRINT
      • COMPANY PRODUCT FOOTPRINT
    • COMPETITIVE BENCHMARKING
      • Table TISSUE DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES/APPROVALS
        • Table KEY PRODUCT LAUNCHES
      • DEALS
        • Table KEY DEALS
      • OTHER DEVELOPMENTS
        • Table KEY OTHER DEVELOPMENTS
  • COMPANY PROFILES
    • KEY PLAYERS
      • F. HOFFMANN-LA ROCHE LTD
        • Table F. HOFFMANN-LA ROCHE LTD: BUSINESS OVERVIEW
      • DANAHER CORPORATION
        • Table DANAHER CORPORATION: BUSINESS OVERVIEW
      • THERMO FISHER SCIENTIFIC INC.
        • Table THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
      • ABBOTT
        • Table ABBOTT: BUSINESS OVERVIEW
      • AGILENT TECHNOLOGIES INC.
        • Table AGILENT TECHNOLOGIES INC.: BUSINESS OVERVIEW
      • MERCK KGAA
        • Table MERCK KGAA: BUSINESS OVERVIEW
      • SAKURA FINETEK JAPAN CO., LTD.
        • Table SAKURA FINETEK JAPAN CO., LTD.: BUSINESS OVERVIEW
      • ABCAM PLC.
        • Table ABCAM PLC.: BUSINESS OVERVIEW
      • BECTON, DICKINSON AND COMPANY (BD)
        • Table BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
      • BIO SB
        • Table BIO SB: BUSINESS OVERVIEW
      • BIOGENEX
        • Table BIOGENEX.: BUSINESS OVERVIEW
      • CELL SIGNALING TECHNOLOGY, INC.
        • Table CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW
      • HISTO-LINE LABORATORIES
        • Table HISTO-LINE LABORATORIES: BUSINESS OVERVIEW
      • SLEE MEDICAL GMBH
        • Table SLEE MEDICAL GMBH.: BUSINESS OVERVIEW
      • AMOS SCIENTIFIC PTY LTD
        • Table AMOS SCIENTIFIC PTY LTD: BUSINESS OVERVIEW
      • JINHUA YIDI MEDICAL APPLIANCE CO. LTD
        • Table JINHUA YIDI MEDICAL APPLIANCE CO.LTD: BUSINESS OVERVIEW
      • MEDITE MEDICAL GMBH
        • Table MEDITE MEDICAL GMBH: BUSINESS OVERVIEW
      • CELLPATH LTD
        • Table CELLPATH LTD: BUSINESS OVERVIEW
      • HOLOGIC, INC
        • Table HOLOGIC, INC: BUSINESS OVERVIEW
      • DIAPATH S.P.A.
        • Table DIAPATH S.P.A.: BUSINESS OVERVIEW
      • KFBIO KONFOONG BIOINFORMATION TECH CO., LTD
        • Table KFBIO KONFOONG BIOINFORMATION TECH CO., LTD: BUSINESS OVERVIEW
      • DIAGNOSTIC BIOSYSTEMS INC.
        • Table DIAGNOSTIC BIOSYSTEMS INC.: BUSINESS OVERVIEW
      • 3DHISTECH LTD.
        • Table 3DHISTECH LTD: BUSINESS OVERVIEW
      • RWD LIFE SCIENCE CO., LTD.
        • Table RWD LIFE SCIENCE CO., LTD.: BUSINESS OVERVIEW
      • DAKEWEI BIOTECHNOLOGY CO., LTD.
        • Table DAKEWEI BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • APPENDIX
    • INDUSTRY INSIGHTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings